Export ready

Your pitch deck is ready

Longitudinal Patient History Summarization Agent

12 slides. One click to download a shareable PDF with contact details included.

Back to presentation

Preview

01 / 12

cover

Stellitron

Intelligent Agentic Memory for Longitudinal Clinical Synthesis

Contact listed in the concept

contact@stellitron.com

Tagline

Proposed funding ask

$5,000,000

Proposed value

Autonomous EMR Data Synthesis
Persistent Clinical Reasoning
Specialist-Context Awareness

02 / 12

problem

The Data Overload Crisis

The challenge

Specialists are drowning in fragmented, multi-year EMR data, spending an average of 20 minutes per patient on manual record reconstruction.

Pain points

Physician burnout at record highs due to documentation fatigue
Critical diagnostic errors from missed longitudinal trends
Inefficient specialist handovers costing health systems millions

Research claim

Label: Avg. time spent per new patient on manual history prep
Value: 20 Mins
Source: Clinical Informatics Review 2025

03 / 12

solution

The Stellitron Solution

Steps

Desc: Prioritizes data based on specialist type (e.g., Cardiac labs for Cardiologists).
Title: Autonomous Planning

Desc: Maintains clinical reasoning over time, evolving with the patient journey.
Title: Persistent Memory

Description

An AI-native agentic workflow using persistent memory and hierarchical planning to autonomously crawl FHIR-compliant records into context-aware briefs.

04 / 12

market

Market Opportunity

Serviceable market

$12.5 Billion (Cloud EMR Specialist Market)

Obtainable market

$850 Million (High-Volume Specialty Clinics)

Total addressable market

$45 Billion (Global Healthcare AI & EMR)

Quote

The shift from generative chat to autonomous clinical agents is the defining trend of 2025.

05 / 12

competition

Competitive Landscape

Features

Generated feature comparison · unverified
Feature	Particle Health	Abridge	Stellitron
Specialist Planning	Low	Low	High
Persistent Memory	Low	Medium	High
EHR Integration	High	High	High

Competitors

Particle Health
Abridge
Stellitron

06 / 12

business model

Business Model

Streams

Desc: Annual recurring revenue based on seat count and specialty modules.
Title: B2B SaaS Subscription
Value: $15k - $50k / clinic

Desc: Volume-based pricing for high-throughput academic medical centers.
Title: Usage-Based Processing
Value: $1.50 / summary

Desc: Implementation and private API bridge setup for large health systems.
Title: Enterprise Integration
Value: $100k+ / one-time

07 / 12

traction

Traction & Validation

Metrics

Generated metric claims · unverified
Label	Value
Beta Completion	Q4 2025
Pilot Expansion	Q1 2026
LTV/CAC	11.25x

Unverified testimonial

Stellitron has reduced our pre-visit prep time by 70%, allowing our specialists to focus entirely on the patient.

08 / 12

financials

Financial Projections

Projected indicators

LTV / CAC: 11.25x
Year 5 EBITDA: 32%
CAC payback: 11 Months

Revenue projections

Generated revenue projections by year · unverified
Year	Revenue
Y1	450k
Y2	2.2M
Y3	7.5M
Y4	18.0M
Y5	42.5M

09 / 12

ask

The Ask

Round

Series A

Amount

$5,000,000

Runway

24 Months

Allocation

GTM & Sales: 20%
Ops & Legal: 10%
Clinical & Regulatory: 20%
Engineering & Product: 50%

10 / 12

exit

Exit Strategy

Scenarios

Type: Health System Acquisition
Timeframe: 7-9 years
Valuation: $550M
Probability: Strategic Fit
Potential Acquirers: UnitedHealth Group
CVS Health

Type: EHR Vendor Integration
Timeframe: 5-7 years
Valuation: $340M
Probability: High Probability

Type: AI Consolidation
Timeframe: 4-6 years
Valuation: $212M
Probability: Medium Probability

Comparable Exits

Year: 2025
Company: Abridge (Valuation)
Exit Type: Funding/Valuation
Exit Value: $5.3B

11 / 12

risks

Risk Analysis

Risks

Risk: LLM Hallucinations in Clinical Summaries
Category: Technical
Mitigation: Human-in-the-loop UI and RAG architecture for source-linked citations.

Risk: Incumbent EMR Disintermediation
Category: Market
Mitigation: Deep integration hooks and focus on cross-institutional data portability.

Risk: FDA SaMD Classification
Category: Regulatory
Mitigation: Positioned as Clinical Decision Support (CDS) to remain Class I.

12 / 12

sources

Sources & References

Contact listed in the concept

contact@stellitron.com

Sources

Source link: https://www.klover.ai/cvs-health-ai-strategy
Type: Market Analysis
Title: CVS Health's AI Strategy Dominance

Source link: https://www.reuters.com/business/healthcare-startup-abridge
Type: Funding Data
Title: Abridge $5.3B Valuation Report

Source link: https://topflightapps.com/ideas/ai-in-ehr/
Type: Industry Report
Title: AI in EHR: Benefits & Costs 2025

Disclaimer

This pitch deck is AI-generated for illustrative purposes. All financial projections and market data are estimates and should be validated with professional advisors.

Data sources

Exa AI Web Search
ArXiv Healthcare Agent Orchestrator Research
Stellitron Internal Financial Models

Generated by

Stellitron AI

The PDF includes a contact slide and a clickable link to reach us on every page.

stellitron.com/contact